Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNEN/59.10.880PMID 11079778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  2002cited by this paper
• Cyclin' toward dementia

  2000cited by this paper
• Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.

  1999cited by this paper
• The role of cell cycle‐mediated events in Alzheimer's disease

  1999cited by this paper
• A selective imaging of tinnitus.

  1999cited by this paper
• Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases

  1999cited by this paper
• Cell cycle events in neurons. Proliferation or death?

  1999cited by this paper
• Cooperation of p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways during Granulocyte Colony-stimulating Factor-induced Hemopoietic Cell Proliferation*

  1999cited by this paper
• p38 Mitogen-activated Protein Kinase Activation Is Required for Fibroblast Growth Factor-2-stimulated Cell Proliferation but Not Differentiation*

  1999cited by this paper
• p38 Kinase Is Activated in the Alzheimer's Disease Brain

  1999cited by this paper
• Role of p38 MAP kinase in myocardial stress.

  1998cited by this paper
• Requirement of p38 Mitogen-activated Protein Kinase for Neuronal Differentiation in PC12 Cells*

  1998cited by this paper
• Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family*

  1998cited by this paper
• Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease

  1998cited by this paper
• A Role for the p38 Mitogen-activated Protein Kinase Pathway in Myocardial Cell Growth, Sarcomeric Organization, and Cardiac-specific Gene Expression

  1997cited by this paper
• Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.

  1997cited by this paper
• Hemopoietic Growth Factors with the Exception of Interleukin-4 Activate the p38 Mitogen-activated Protein Kinase Pathway*

  1997cited by this paper
• Reactivating kinase/p38 phosphorylates tau protein in vitro.

  1997influential reference
• Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

  1997influential reference
• Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells.

  1997cited by this paper
• Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

  1997cited by this paper
• Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

  1997cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27.

  1997cited by this paper
• Reactivating Kinase/p38 Phosphorylates τ Protein In Vitro

  1997cited by this paper
• Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways

  1996cited by this paper
• Mitotic mechanisms in Alzheimer's disease?

  1996cited by this paper
• Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation*

  1996cited by this paper
• Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease

  1995influential reference
• Hydrogen peroxide and the proliferation of BHK-21 cells.

  1995cited by this paper
• Hydrogen peroxide-and fetal bovine serum-induced DNA synthesis in vascular smooth muscle cells: positive and negative regulation by protein kinase C isoforms.

  1995cited by this paper
• β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding

  1995cited by this paper
• Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide

  1995cited by this paper
• Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

  1994cited by this paper
• Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia

  1994cited by this paper
• Alzheimer Disease

  1994cited by this paper
• Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines.

  1994cited by this paper
• Immunohistochemical evidence of antioxidant stress in Alzheimer's disease

  1992cited by this paper
• p42 map kinase phosphorylation sites in microtubule‐associated protein tau are dephosphorylated by protein phosphatase 2A1 Implications for Alzheimer's disease

  1992cited by this paper
• Fitness: Historical perspective

  1992cited by this paper
• Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.

  1992cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Alterations in the Neuronal Cytoskeleton in Alzheimer Disease

  1988cited by this paper
• Diagnosis of Alzheimer's disease.

  1988cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Phosphorylation affects the ability of tau protein to promote microtubule assembly.

  1984cited by this paper
• ADVANCES IN BEHAVIORAL BIOLOGY

  1972cited by this paper
• International Review of Neurobiology

  1961cited by this paper

• Ramalin Ameliorates Alzheimer's Disease Pathology by Targeting BACE1, HDAC6, and MAPK Pathways

  2026cites this paper
• Noninvasive Detection of Oxidative Stress in a Mouse Model of 4R Tauopathy via Positron Emission Tomography with [18F]ROStrace

  2025cites this paper
• Understanding of Alzheimer's Disease Pathophysiology for Therapeutic Implications of Natural Products as Neuroprotective Agents.

  2025cites this paper
• Beyond Radical Scavengers: Focus on NADPH Oxidases (NOX) Inhibitors as New Agents for Antioxidant Therapy in Alzheimer’s Disease

  2025cites this paper
• Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease

  2025cites this paper
• Cellular and molecular mechanisms of pathological tau phosphorylation in traumatic brain injury: implications for chronic traumatic encephalopathy

  2025cites this paper
• Human Stress Response Specificity through Bioresonance Selectivity

  2025cites this paper
• Leveraging targeted kinase degradation as a novel therapeutic strategy for Alzheimer's disease

  2025cites this paper
• Tailoring MAPK Pathways: New Therapeutic Avenues for Treating Alzheimer’s Disease

  2025cites this paper
• Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer's disease.

  2025cites this paper
• Site-Specific Regulation of Tau phosphorylation by MAPK pathways during HFS-Induced synaptic plasticity in the Rat hippocampus.

  2025cites this paper
• Activation of the Neuronal Cell Cycle in Brains in Amnestic Mild Cognitive Impairment: Early Involvement in the Progression of Alzheimer’s Disease

  2024cites this paper
• Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment.

  2024cites this paper
• Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure

  2024cites this paper
• Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease.

  2024cites this paper
• Potential Alzheimer’s disease drug targets identified through microglial biology research

  2024cites this paper
• Activation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs

  2024cites this paper
• Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease

  2024cites this paper
• Neuroprotective effects of Shenghui decoction via inhibition of the JNK/p38 MAPK signaling pathway in an AlCl3-induced zebrafish (Danio rerio) model of Alzheimer's disease.

  2024cites this paper
• p38α Mitogen-Activated Protein Kinase—An Emerging Drug Target for the Treatment of Alzheimer’s Disease

  2024cites this paper
• Polyamine Dysregulation and Nucleolar Disruption in Alzheimer’s Disease

  2024cites this paper
• Somatostatin and the pathophysiology of Alzheimer's disease.

  2024cites this paper
• Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice

  2024cites this paper
• Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

  2024cites this paper
• Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.

  2023cites this paper
• Tau, tau kinases, and tauopathies: An updated overview

  2023cites this paper
• Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.

  2023cites this paper
• Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectives.

  2023cites this paper
• Reinstated Activity of Human Tau-induced Enhanced Insulin Signaling Restricts Disease Pathogenesis by Regulating the Functioning of Kinases/Phosphatases and Tau Hyperphosphorylation in Drosophila

  2023cites this paper
• Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer's disease and diabetes.

  2023cites this paper
• Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?

  2023cites this paper
• Ferroptosis mechanism and Alzheimer's disease

  2023cites this paper
• MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease

  2023cites this paper
• Drosophila Toll-9 is induced by aging and neurodegeneration to modulate stress signaling and its deficiency exacerbates tau-mediated neurodegeneration

  2023cites this paper
• Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials

  2023cites this paper
• The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer’s disease

  2022cites this paper
• Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

  2022cites this paper
• FAK-Mediated Signaling Controls Amyloid Beta Overload, Learning and Memory Deficits in a Mouse Model of Alzheimer’s Disease

  2022cites this paper
• Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease

  2022cites this paper
• p38 activation occurs mainly in microglia in the P301S Tauopathy mouse model

  2022cites this paper
• Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

  2021cites this paper
• Sustained Interleukin-1β overexpression exacerbates Tau pathology in a murine tauopathy model via cyclooxygenase-1

  2021cites this paper
• P38α‐MAPK phosphorylates Snapin and reduces Snapin‐mediated BACE1 transportation in APP‐transgenic mice

  2021cites this paper
• Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer's disease.

  2021cites this paper
• Correction to: Acetaldehyde induces tau phosphorylation via activation of p38 MAPK/JNK and ROS production

  2021cites this paper
• Oxidative stress‐A direct bridge to central nervous system homeostatic dysfunction and Alzheimer's disease

  2021cites this paper
• Advances in Proteasome Enhancement by Small Molecules

  2021cites this paper
• Post-translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease: A Review of the Literature

  2021cites this paper
• Nuclear dynamics and stress responses in Alzheimer’s disease

  2021cites this paper
• Mitochondria in the Cerebral and Cerebellar Cortex in Alzheimer’s Disease, Target for a Therapeutic Approach

  2021cites this paper
• Dysregulated protein phosphorylation as main contributor of granulovacuolar degeneration at the first stages of NFT pathology.

  2021cites this paper
• The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer’s Disease

  2021cites this paper
• Acetaldehyde induces tau phosphorylation via activation of p38 MAPK/JNK and ROS production

  2021cites this paper
• Studies of aging nonhuman primates illuminate the etiology of early‐stage Alzheimer's‐like neuropathology: An evolutionary perspective

  2021cites this paper
• Interleukin-10 deficiency exacerbates inflammation-induced tau pathology

  2021cites this paper
• Genetic Dissection of Alzheimer’s Disease Using Drosophila Models

  2020cites this paper
• “Olfactory Three-Needle” Enhances Spatial Learning and Memory Ability in SAMP8 Mice

  2020cites this paper
• Targeting tau hyperphosphorylation via kinase inhibition- Strategy to address Alzheimers' disease.

  2020cites this paper
• Cytoplasmic mislocalization and mitochondrial colocalization of TDP-43 are common features between normal aged and young mice

  2020cites this paper
• Is granulovacuolar degeneration an essential pathological component of Alzheimer's disease? A review of the pathogenesis and histochemistry of old studies.

  2020cites this paper
• c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s Diseases

  2020cites this paper
• The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease

  2020cites this paper
• Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies

  2020cites this paper
• Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease

  2020cites this paper
• Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis

  2020cites this paper
• Regulation of senescence traits by MAPKs

  2020cites this paper
• Neuronal deficiency of p38α‐MAPK ameliorates symptoms and pathology of APP or Tau‐transgenic Alzheimer’s mouse models

  2020cites this paper
• Treating Alzheimer’s disease pathology: Present to alternative modalities

  2020cites this paper
• Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease

  2019cites this paper
• Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology

  2019cites this paper
• p38 MAPK–dependent alphaB‐crystallin phosphorylation in Alzheimer's disease–like pathology in OXYS rats

  2019cites this paper
• Screening of a neuronal cell model of tau pathology for therapeutic compounds.

  2019cites this paper
• Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases.

  2019cites this paper
• Modulating Effect of Diet on Alzheimer’s Disease

  2019cites this paper
• PATHOLOGICAL TAU AS A CAUSE, AND CONSEQUENCE, OF CELLULAR DYSFUNCTION

  2019cites this paper
• Nonenzymatic Posttranslational Protein Modifications: Mechanism and Associated Disease Pathologies

  2019cites this paper
• Acute exercise and brain BACE1 protein content: a time course study

  2019cites this paper
• Natural products as a potential modulator of microglial polarization in neurodegenerative diseases.

  2019cites this paper
• Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity

  2018cites this paper
• Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer’s Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells

  2018cites this paper
• Peroxisome proliferator-activated receptor alpha accelerates neuronal differentiation and this might involve the mitogen-activated protein kinase pathway

  2018cites this paper
• Activation of &agr;7 nicotinic acetylcholine receptor alleviates A&bgr;1‐42‐induced neurotoxicity via downregulation of p38 and JNK MAPK signaling pathways

  2018cites this paper
• Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles.

  2018cites this paper
• Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer’s Disease

  2018cites this paper
• Molecular Modeling of Tau Proline-Directed Protein Kinase (PDPK) Inhibitors

  2018cites this paper
• Evaluation of neuropathological effects of a high‐fat high‐sucrose diet in middle‐aged male C57BL6/J mice

  2018cites this paper
• A new tool for studying waterfowl immune and metabolic responses: Molecular level analysis using kinome profiling

  2018cites this paper
• Expression of genes that encode cellular oxidant/antioxidant systems are affected by heat stress

  2018cites this paper
• Mechanism involved in insulin resistance via accumulation of β -amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

  2018cites this paper
• U1 snRNP Alteration and Neuronal Cell Cycle Reentry in Alzheimer Disease

  2018cites this paper
• Mechanism involved in insulin resistance via accumulation of β -amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

  2018cites this paper
• Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease

  2018cites this paper
• Could Alzheimer’s Disease Originate in the Periphery and If So How So?

  2018cites this paper
• Phosphorylation of microtubule-associated protein tau by mitogen-activated protein kinase in Alzheimer’s disease

  2018cites this paper
• Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

  2018cites this paper
• APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.

  2018cites this paper
• Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy

  2018cites this paper
• Depotentiation of Long-Term Potentiation Is Associated with Epitope-Specific Tau Hyper-/Hypophosphorylation in the Hippocampus of Adult Rats

  2018cites this paper
• Mechanism involved in insulin resistance via accumulation of β -amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

  2018cites this paper
• Inhibitors of Tau-Phosphorylating Kinases

  2017cites this paper